Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia

Vasculogenic therapies explored for the treatment of peripheral artery disease (PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform of protein phosphatase 2A (PP2A), emerges as pivotal in vessel remodeling through activation of hypoxia-inducible factor 1α (HIF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: García-Martín, Adela (VerfasserIn) , Prados, María E. (VerfasserIn) , Lastres-Cubillo, Isabel (VerfasserIn) , Ponce-Diaz, Francisco J. (VerfasserIn) , Cerero, Laura (VerfasserIn) , Garrido-Rodriguez, Martin (VerfasserIn) , Navarrete, Carmen (VerfasserIn) , Pineda, Rafael (VerfasserIn) , Rodríguez, Ana B. (VerfasserIn) , Muñoz, Ignacio (VerfasserIn) , Moya, Javier (VerfasserIn) , Medeot, Antonella (VerfasserIn) , Moreno, José A. (VerfasserIn) , Chacón, Antonio (VerfasserIn) , García-Revillo, José (VerfasserIn) , Muñoz, Eduardo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2024
In: Journal of translational medicine
Year: 2024, Jahrgang: 22, Pages: [2]-24
ISSN:1479-5876
DOI:10.1186/s12967-024-05748-w
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12967-024-05748-w
Volltext
Verfasserangaben:Adela García-Martín, María E. Prados, Isabel Lastres-Cubillo, Francisco J. Ponce-Diaz, Laura Cerero, Martin Garrido-Rodríguez, Carmen Navarrete, Rafael Pineda, Ana B. Rodríguez, Ignacio Muñoz, Javier Moya, Antonella Medeot, José A. Moreno, Antonio Chacón, José García-Revillo and Eduardo Muñoz
Beschreibung
Zusammenfassung:Vasculogenic therapies explored for the treatment of peripheral artery disease (PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform of protein phosphatase 2A (PP2A), emerges as pivotal in vessel remodeling through activation of hypoxia-inducible factor 1α (HIF-1α). This study delves into the pharmacological profile of VCE-004.8 (Etrinabdione) and evaluates its efficacy in a preclinical model of critical limb ischemia, with a focus on its potential as a PP2A/B55α activator to induce angiogenesis and arteriogenesis.
Beschreibung:Online veröffentlicht: 6. November 2024
Gesehen am 05.06.2025
Beschreibung:Online Resource
ISSN:1479-5876
DOI:10.1186/s12967-024-05748-w